Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain
- 1 March 2006
- journal article
- research article
- Published by Elsevier BV in The American Journal of Clinical Nutrition
- Vol. 83 (3), 606-612
- https://doi.org/10.1093/ajcn.83.3.606
Abstract
Conjugated linoleic acid (CLA) is marketed as a safe, simple, and effective dietary supplement to promote the loss of body fat and weight. However, most previous studies have been of short duration and inconclusive, and some recent studies have questioned the safety of long-term supplementation with CLA. Our aim was to assess the effect of 1-y supplementation with CLA (3.4 g/d) on body weight and body fat regain in moderately obese people. One hundred twenty-two obese healthy subjects with a body mass index (in kg/m2) > 28 underwent an 8-wk dietary run-in with energy restriction (3300-4200 kJ/d). One hundred one subjects who lost >8% of their initial body weight were subsequently randomly assigned to a 1-y double-blind CLA (3.4 g/d; n = 51) or placebo (olive oil; n = 50) supplementation regime in combination with a modest hypocaloric diet of -1250 kJ/d. The effects of treatment on body composition and safety were assessed with the use of dual-energy X-ray absorptiometry and with blood samples and the incidence of adverse events, respectively. After 1 y, no significant difference in body weight or body fat regain was observed between the treatments. The CLA group (n = 40) regained a mean (+/-SD) 4.0 +/- 5.6 kg body weight and 2.1 +/- 5.0 kg fat mass compared with a regain of 4.0 +/- 5.0 kg body weight and 2.7 +/- 4.9 kg fat mass in the placebo group (n = 43). No significant differences in reported adverse effects or indexes of insulin resistance were observed, but a significant increase in the number of leukocytes was observed with CLA supplementation. A 3.4-g daily CLA supplementation for 1 y does not prevent weight or fat mass regain in a healthy obese population.Keywords
This publication has 22 references indexed in Scilit:
- Conjugated linoleic acid and obesity control: efficacy and mechanismsInternational Journal of Obesity, 2004
- Dietary supplements for body-weight reduction: a systematic reviewThe American Journal of Clinical Nutrition, 2004
- Efficacy and safety of dietary supplements containing CLA for the treatment of obesityJournal of Lipid Research, 2003
- Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker ratAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjectsInternational Journal of Obesity, 2003
- Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy menEuropean Journal of Clinical Nutrition, 2003
- Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouseJournal of Lipid Research, 2002
- Conjugated Linoleic Acid May Be Useful in Treating Diabetes by Controlling Body Fat and Weight GainDiabetes Technology & Therapeutics, 2002
- White blood cell countJournal of Clinical Epidemiology, 2001
- Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteersEuropean Journal of Lipid Science and Technology, 2000